Stephen Kalscheuer

Folic Acid Functionalized Nanoparticles for Enhanced Oral Drug Delivery

Emilie Roger, Stephen Kalscheuer, Ameya R. Kirtane et al. · Molecular Pharmaceutics · 2012 · 175 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

Stephen Kalscheuer, Xiaoxiao Zhang, Yan Zeng et al. · Carcinogenesis · 2008 · 130 citations · Full text

Medicine, Molecular Biology, Oncology +17

Discovery of HSPG2 (Perlecan) as a Therapeutic Target in Triple Negative Breast Cancer

Stephen Kalscheuer, Vidhi Khanna, Hyunjoon Kim et al. · Scientific Reports · 2019 · 50 citations · Full text

Medicine, Cancer Biology, Oncology +14

Quantitation of Pyridylhydroxybutyl-DNA Adducts in Liver and Lung of F-344 Rats Treated with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol

Pramod Upadhyaya, Stephen Kalscheuer, J. Bradley Hochalter et al. · Chemical Research in Toxicology · 2008 · 45 citations · Full text

Medicine, Pharmacology, Toxicology +16

Perlecan-Targeted Nanoparticles for Drug Delivery to Triple-Negative Breast Cancer

Vidhi Khanna, Stephen Kalscheuer, Ameya R. Kirtane et al. · Future Drug Discovery · 2019 · 44 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17